Antisoma is a biotechnology company specialising in the development of novel drugs for the treatment of cancer. Our strategy is to acquire promising early-stage drug candidates from academic and commercial institutions around the world, to manage the development of these drugs through preclinical testing and clinical trials, and to bring them to the market
